Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY – Get Free Report) is anticipated to post its quarterly earnings results on Wednesday, February 26th. Analysts expect Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to post earnings of $0.17 per share and revenue of $19.10 billion for the quarter.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Stock Performance
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München stock opened at $10.78 on Monday. The company has a market cap of $72.10 billion, a PE ratio of 7.01, a P/E/G ratio of 1.72 and a beta of 1.03. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a 12 month low of $8.44 and a 12 month high of $11.28. The company has a fifty day moving average price of $10.59 and a two-hundred day moving average price of $10.51. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.12 and a quick ratio of 1.12.
Analyst Upgrades and Downgrades
MURGY has been the topic of several research reports. Barclays upgraded shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to a “strong-buy” rating in a research note on Tuesday, January 28th. UBS Group cut Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “strong-buy” rating to a “hold” rating in a research report on Thursday, December 19th.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Company Profile
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.
See Also
- Five stocks we like better than Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
- Insider Buying Explained: What Investors Need to Know
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- What is a SEC Filing?
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What is a Special Dividend?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München and related companies with MarketBeat.com's FREE daily email newsletter.